1.42 (3.65%)
Last updated: 17:00
Fundamental   5.4  
Technical   7.4  
Total Score   12.8  

 Insti+   SAT+   Chart Pattern+   Sector Trend+ 
Dpharma chart by TradingView

iSaham Fundamental Trend - DPHARMA

FCON: 0.64 | Sharpe Ratio: 0.42 | LTS: 7.4

Financial Ratios - DPHARMA

EPS 9.44 sen
Trailing PE (Sector Median: 15.3) 19.6
PEG -5.89
Altman Z 2.9
Beaver 0.2
Current Ratio 1.65
Debt-Equity (DE) Ratio 0.74
FCF Yield -0.0 %
Dividend Per Share (DPS) 1.99 sen
Revenue QoQ 3.01 %
Revenue YoY 52.96 %
Profit QoQ 21.05 %
Profit YoY 12.44 %
NTA QoQ -33.33 %
Profit Margin (Sector Median: 5.5) 9.58 %
ROE 9.92 %
ROIC 7.63 %
Dividend Yield (DY) 1.4 %

Support & Resistance

ATR Trailing Stop: 1.33

Last Price
Price 1.27 1.29 1.3 1.33 1.38 1.42 1.45 1.46 1.47 1.49
Volume (M) 14.0 20.1 17.2 1.2 11.6 5.6 13.7 5.6 1.9

Gann Support (EP/CL): 1.39/1.33 | Resistance (TP): 1.45/1.51

*Highlighted column shows significant volume at the support or resistance area.

Technical Trend

Moving Average Trend
Volume Trend

Trading Signalsbeta - DPHARMA

Based on iSaham Screeners

Moving Average (Short Term) BUY
Moving Average (Mid Term) BUY
Moving Average (Long Term) BUY
Ichimoku Kumo BUY
Bollinger Band BUY (Breakout)
Stochastic BUY
Heikin-Ashi BUY
MACD BUY (Above 0)
Solid MA Trend BUY
Sector Trend (Long Term) BUY
Sector Trend (Short Term) BUY
Institutional Holdings BUY
Beat The Insti BUY
Magic Formula -
Better Than ASB -
52-Week High -
T+ -
Candlestick -
Chart Pattern BUY

Please be fully informed regarding the risks and costs associated with trading in the stock markets. Any trade you made must be followed by your own judgement and analysis. Please read our risk disclosure for more info.

Fair Value

iSaham Fair Value: 0.81

Discounted Cash Flow (DCF)5.0% Growth 0.81
Discounted Cash Flow (DCF)-2.8% Growth 0.555
Relative Valuation 1.11
Graham Formula 0.715
Graham Number 1.25
Net Tangible Asset (NTA) 4.0

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 98.11
Expected Revenue (M) 1024.13
Expected Growth (%) 13.0


Market Cap: 938 M.

Number of Shares: 661 M.

Float: 40.43%.

Stock highly correlated with

DLADY (77%)

HLIND (77%)

TCHONG (76%)


CCM Duopharma Biotech Berhad, an investment holding company, is engaged in the manufacture, distribution, import, and export of pharmaceutical products and medicines in Malaysia. It offers various over the-counter products, including oral antibiotics, cough syrups, analgesic/anti-pyretics, anti-bacterial mouthwash, children's vitamins, haemodialysis solutions, dental cartridges, and eye drop preparations. The company exports its products to various countries, including Vietnam, Ethiopia, Sudan, Southeast Asia, Papua New Guinea, Pakistan, Bangladesh, Sri Lanka, Republic of Yemen, Singapore, and Hong Kong. Founded in 1979, the company is based in Klang, Malaysia. CCM Duopharma Biotech Berhad is a subsidiary of CCM Marketing Sdn. Bhd.

Code: 7148

Website: http://duopharmabiotech.com/

Related Links: Bursa | Analyst Report | Annual Report | Announcement

Top Shareholdings

Shareholder Value (M)
Permodalan Nasional Berhad 185.66
Employees Provident Fund Board 26.08
Amanah Saham Bumiputera 13.49
Billion Victory Sdn Bhd 10.39
Kumpulan Wang Persaraan (Diperbadankan) 4.54
Public Islamic Treasures Growth Fund 4.25
Tokio Marine Life Insurance Malaysia Bhd 3.72
Leong Chao Seong 2.92
Kenanga Growth Fund 2.68
Credit Suisse 2.41
Kaf Dana Adib 2.04
Affin Hwang Principled Growth Fund 1.98
CIMB Islamic Small Cap Fund 1.84
AS 1Malaysia 1.79
Kenanga Malaysian Inc Fund 1.78
Affin Hwang Asset Management Berhad 1.68
National Trust Fund 1.51
Kaf tactical Fund 1.5
Manulife Investment Progress Fund 1.46
Etiqa Life Insurance Berhad 1.42
Amtotal Return 1.41
Ooi Keng Tan 1.26
Affin Hwang Flexi Fund II 1.25
G.T.Y. Holdings Sdn Bhd 1.23